A detailed history of Jain Global LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Jain Global LLC holds 23,590 shares of DVAX stock, worth $260,905. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,590
Previous 66,075 64.3%
Holding current value
$260,905
Previous $655,000 64.27%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$9.36 - $11.36 $397,659 - $482,629
-42,485 Reduced 64.3%
23,590 $234,000
Q2 2025

Aug 14, 2025

BUY
$9.4 - $12.87 $621,105 - $850,385
66,075 New
66,075 $655,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.4B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Jain Global LLC Portfolio

Follow Jain Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jain Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jain Global LLC with notifications on news.